{"id":"W1995357901","doi":"10.3109/10428194.2010.490312","title":"Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts","year":2010,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Daunorubicin; Cytarabine; Pharmacology; Medicine; Bone marrow; Leukemia; Drug; Therapeutic index; Myeloid leukemia; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001981617,0.00025218,0.0002085712,0.0001823783,0.00009513499,0.0001926541,0.0001841303,0.0001788099,0.0004455761],"category_scores_gemma":[0.0001569475,0.0001330901,0.0001459108,0.0001576464,0.0001529599,0.0002211693,0.0001108698,0.0004259684,0.0001550558],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002521884,"about_ca_system_score_gemma":0.0002054256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007205475,"about_ca_topic_score_gemma":0.001461824,"domain_scores_codex":[0.999886,0.00002358159,0.00000934304,0.00002573435,0.00003078475,0.00002464027],"domain_scores_gemma":[0.9998943,0.00002644644,0.00003339205,0.000009746709,0.00001332217,0.00002283459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005469512,0.000208498,0.0003201131,0.00004962098,0.000008518605,0.00002092965,0.00003575671,0.0009779115,0.9892058,0.00007955179,0.00007606559,0.008470296],"study_design_scores_gemma":[0.0000476329,0.004238781,0.006141237,0.000005015618,0.00003070926,0.0001214383,0.000009707028,0.00175952,0.9861027,0.00001587446,0.001520729,0.000006725606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945695,0.002490098,0.001358938,0.00004326914,0.00001608989,0.00007961298,0.0002380693,0.00006747058,0.001136947],"genre_scores_gemma":[0.9972177,0.0006432674,0.001346526,0.00001567939,0.000006863858,0.00003470844,0.0001884816,0.00001421206,0.0005324109],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007205475,"threshold_uncertainty_score":0.001829743,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01513441191351091,"score_gpt":0.2812551573835176,"score_spread":0.2661207454700067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}